SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics
September 25, 2024 17:46 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
September 25, 2024 17:44 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options If...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Five Below
September 25, 2024 17:39 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Five Below To Contact Him Directly To Discuss Their Options ...
LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results
September 25, 2024 16:45 ET
|
LuxUrban Hotels Inc.
LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
September 25, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
September 25, 2024 07:30 ET
|
LuxUrban Hotels Inc.
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bumble Inc.
September 24, 2024 17:21 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Bumble To Contact Him Directly To Discuss Their Options ...
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
September 24, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
38/2024・Trifork Group AG – Financial Calendar 2025
September 23, 2024 09:30 ET
|
Trifork Group AG
Company announcement no. 38 / 2024 Schindellegi, Switzerland – 23 September 2024 Trifork Group – Financial Calendar 2025 Trifork today publishes its financial calendar for 2025. Q4 and Annual...
BIO-key Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control
September 23, 2024 08:28 ET
|
BIO-key International, Inc.
BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.